GBR-12935是一种哌嗪衍生物,是一种有效和选择性多巴胺再摄取抑制剂。它最初是在3H的放射性物质中发展出来的,目的是通过选择性地标记多巴胺转运蛋白来映射大脑中多巴胺能神经元的分布。
For research use only. We do not sell to patients.
Name | 1-(2-乙基)-4 -(3-苯丙基)哌嗪 |
---|---|
Iupac Chemical Name | 1-(2 (Diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine |
Synonyms | GBR-12935; GBR 12935; GBR12935. |
Molecular Formula | C28H34N2O |
Molecular Weight | 414.593 |
Smile | N1(CCOC(C2=CC=CC=C2)C3=CC=CC=C3)CCN(CCCC4=CC=CC=C4)CC1 |
InChiKey | RAQPOZGWANIDQT-UHFFFAOYSA-N |
InChi | InChI=1S/C28H34N2O/c1-4-11-25(12-5-1)13-10-18-29-19-21-30(22-20-29)23-24-31-28(26-14-6-2-7-15-26)27-16-8-3-9-17-27/h1-9,11-12,14-17,28H,10,13,18-24H2 |
CAS Number | 76778-22-8 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | 白色粉末 |
---|---|
Purity | >98% |
Storage | 短期可在0-4度保存,数天至数月;长期可在-20度保存三年。 |
Solubility | 可溶于DMSO |
Handling | |
Shipping Condition | 可在常温下运输 |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |